购物车里还没有商品。
描述
研究领域
图片与验证
−| 应用说明 |
|---|
关键属性
−| 表达系统 | E.coli |
|---|---|
| 靶点 | Vascular endothelial growth factor A |
| 标签 | C-His |
| 内毒素 | Not analyzed |
| MW | 20 kDa |
| 纯度 | > 95% as determined by SDS-PAGE |
| 蛋白序列 | 27-191/191 |
储存与操作
−| 储存 | Stored at -70°C or -20°C. Avoid repeated freeze/thaw cycles. |
|---|---|
| 浓度 | > 0.5 mg/ml |
| 有效期 | 6 months from date of receipt. |
| 免责声明 | For research use only |
别名
−相似产品
−Recombinant Human VEGFA Protein, C-His [orb1088542]
CLIA, EIA, LF
> 90% as determined by SDS-PAGE
20.8 kDa
HEK293
1 mgVEGF121 Protein, Human, Recombinant (His & Avi), Biotinylated [orb1960084]
98.00%
17 kDa (predicted). Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mgVEGF121 Protein, Human, Recombinant (His & Avi) [orb1960085]
98.00%
17 kDa (predicted). Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mgVEGF165 Protein, Human, Recombinant (His & Avi) [orb1960086]
> 95%
22.2 kDa (predicted). Due to glycosylation, the protein migrates to 28-35 kDa under reduced (R) condition, 45-60 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
1 mg, 100 μg, 500 μgVEGF165 Protein, Human, Recombinant (His & Avi), FITC-Labeled [orb1960087]
> 95%
22.2 kDa (predicted). Due to glycosylation, the protein migrates to 28-33 kDa under reduced (R) condition, 45-55 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
1 mg, 500 μg, 100 μg

质量保证
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our 条款与条件和选购指南.


